Market Cap 5.38B
Revenue (ttm) 980.60M
Net Income (ttm) 53.83M
EPS (ttm) N/A
PE Ratio 41.47
Forward PE 38.75
Profit Margin 5.49%
Debt to Equity Ratio 0.18
Volume 382,200
Avg Vol 516,428
Day's Range N/A - N/A
Shares Out 37.76M
Stochastic %K 90%
Beta 1.67
Analysts Strong Sell
Price Target $175.00

Company Profile

Novanta Inc., together with its subsidiaries, provides precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions in the United States and internationally. The company operates Automation Enabling Technologies and Medical Solutions segments. The Precision Medicine and Manufacturing segment designs, manufactures, and markets laser beam steering and scanning solutions, laser sources, robotic and precision motion, robotic end-of...

Industry: Scientific & Technical Instruments
Sector: Technology
Phone: 781 266 5700
Address:
125 Middlesex Turnpike, Bedford, United States
Estimize
Estimize Jul. 30 at 11:03 AM
Wall St is expecting 0.83 EPS for $NOVT Q2 [Reporting 08/05 AMC] http://www.estimize.com/intro/novt?chart=historical&metric_name=eps&utm_co
0 · Reply
TrendStalker_
TrendStalker_ Jul. 19 at 7:49 PM
Humanoid robotics could become one of the biggest technology themes of the next decade. Goldman Sachs estimates the humanoid robot market could expand nearly 8X by 2035. Key names I’m watching: Sensors, Vision & Perception $OUST $AEVA $NOVT $IPGP The next wave of robotics will depend on more than just AI models. Hardware, sensing systems, and real-world perception will be critical pieces of the ecosystem.
0 · Reply
mattonline1
mattonline1 Jul. 17 at 5:29 PM
$NOVT — HOLD Q1 2026 revenue rose 10.4% YoY to $257.7M, but earnings still fell 13.4%, so the growth profile is not yet converting into cleaner profit. The balance sheet is a plus with net cash and 8.7% TTM free cash flow margin, but the stock already prices in a lot at 5.2x EV/revenue and 36.1x forward P/E. Gross margin of 44.2% shows the embedded product mix has quality, yet operating margin still needs to move toward 13% to 14% before the multiple looks easier to defend. Revenue above $260M and sustained margin expansion would support a higher rating, but at current valuation the setup looks more balanced than compelling. Full research: https://lf0.com/research/novanta-stock-analysis-novt/
0 · Reply
ParkerTradesX
ParkerTradesX Jul. 13 at 6:24 PM
Very hard to be bearish anything robotics, but most of all the actuator, bearings, and actuator components market. Since they account for more than 50% of the total BOM cost. And MS is expecting a 300x growth through to 2050. Here's some of the top names: $RBC: Humanoid opportunity is massive for RBC relative to the ~$50M they generate in revenue today. $RRX: Explained the humanoid opportunity as "when it takes off, it's going to take off quick." Trades far cheaper than RBC. Harmonic Drive (6324): Dominates the precision strain-wave gears inside actuators. And then the indirect winners would be: $NOVT: Robotics is already ~20% of Novanta's revenue with bookings up 50% YoY. $VPG: Quite a popular name on FinX and I think for good reason. Likely a key player in TSLA Optimus overall BOM. Every trading session creates new opportunities. Check profile info for more.
0 · Reply
EquityResearch6
EquityResearch6 Jul. 13 at 5:28 PM
Very hard to be bearish on robotics — especially the actuator, bearings, and actuator components market. Why? These components represent more than 50% of total BOM cost for many humanoid robots. Morgan Stanley expects the humanoid robotics market to grow 300x by 2050. Some names I’m watching: $RBC Humanoid robotics opportunity could be massive compared with its current ~$50M revenue base. $RRX Management described the humanoid opportunity as: “when it takes off, it’s going to take off quick.” Trades at a much lower valuation than $RBC. Harmonic Drive ($6324) Dominates precision strain-wave gears used inside robotic actuators. Indirect beneficiaries: $NOVT Robotics already represents ~20% of revenue, with bookings up 50% YoY. $VPG A popular robotics name with potential exposure to $TSLA Optimus’ overall BOM. The robotics theme is still early. The biggest winners may not just be the robot makers — they may be the companies supplying the critical components that every robot needs.
0 · Reply
UncleSteven
UncleSteven Jul. 7 at 5:37 PM
$NOVT is perhaps not yet "discovered" as a physical AI play. Only ~500 followers here.
0 · Reply
Dauphinoise
Dauphinoise Jul. 7 at 5:22 PM
$NOVT What the fuck happened here?!
1 · Reply
ParkerTradesX
ParkerTradesX Jul. 3 at 3:06 PM
5 Ways I'm Watching the Robotics Theme in 2026 $TER – AI chip testing and collaborative robots through Universal Robots. $NOVT – Precision photonics and motion technology for industrial and surgical robotics. $OUST – LiDAR and perception systems powering physical AI and autonomous machines. $HIMX – Vision and display chips helping robots process images and edge AI workloads. $AMBQ – Ultra-low-power edge AI for intelligent robots and connected devices. Robotics is becoming one of the biggest beneficiaries of the AI infrastructure buildout, and many of these names are still flying under the radar. The next list is about to be released. Are you going to miss out again? Which robotics stock would you add?
0 · Reply
babyloncapital
babyloncapital Jul. 3 at 2:25 PM
$MOG.A $NOVT $TKR starting positions in these names on next significant drop
1 · Reply
BobJohnBuoy666
BobJohnBuoy666 Jul. 2 at 10:39 PM
$NOVT largest position, let’s get this bread
0 · Reply
Latest News on NOVT
Novanta completes acquisition of Riverpoint Medical

2026-07-27T12:16:10.000Z - 8 days ago

Novanta completes acquisition of Riverpoint Medical


Novanta Completes Acquisition of Riverpoint Medical

Jul 27, 2026, 8:00 AM EDT - 8 days ago

Novanta Completes Acquisition of Riverpoint Medical


Novanta registers to sell 2.14M common shares for holders

2026-06-29T21:15:14.000Z - 5 weeks ago

Novanta registers to sell 2.14M common shares for holders


Novanta Transcript: M&A announcement

Jun 9, 2026, 8:30 AM EDT - 2 months ago

Novanta Transcript: M&A announcement


Novanta Slides: M&A announcement

Jun 9, 2026, 8:30 AM EDT - 2 months ago

Novanta Slides: M&A announcement


Novanta Press release: M&A announcement

Jun 9, 2026, 8:30 AM EDT - 2 months ago

Novanta Press release: M&A announcement


Novanta price target raised to $180 from $173 at Baird

2026-06-09T11:26:13.000Z - 2 months ago

Novanta price target raised to $180 from $173 at Baird


Novanta announces $300M private placement

2026-06-09T10:22:32.000Z - 2 months ago

Novanta announces $300M private placement


Novanta Inc. Announces $300 Million Private Placement

Jun 9, 2026, 6:15 AM EDT - 2 months ago

Novanta Inc. Announces $300 Million Private Placement


Novanta acquires Riverpoint Medical for $1.45B

2026-06-09T10:12:04.000Z - 2 months ago

Novanta acquires Riverpoint Medical for $1.45B


Novanta Inc. Announces Acquisition of Riverpoint Medical

Jun 9, 2026, 6:00 AM EDT - 2 months ago

Novanta Inc. Announces Acquisition of Riverpoint Medical


Novanta Transcript: AGM 2026

May 28, 2026, 3:00 PM EDT - 2 months ago

Novanta Transcript: AGM 2026


Novanta Slides: Investor presentation

May 26, 2026, 7:00 AM EDT - 2 months ago

Novanta Slides: Investor presentation


Novanta price target raised to $173 from $144 at Baird

2026-05-13T13:28:11.000Z - 2 months ago

Novanta price target raised to $173 from $144 at Baird


Novanta Earnings Call Transcript: Q1 2026

May 12, 2026, 8:00 AM EDT - 3 months ago

Novanta Earnings Call Transcript: Q1 2026


Novanta Earnings release: Q1 2026

May 12, 2026, 8:00 AM EDT - 3 months ago

Novanta Earnings release: Q1 2026


Novanta Quarterly report: Q1 2026

May 12, 2026, 8:00 AM EDT - 3 months ago

Novanta Quarterly report: Q1 2026


Novanta reports Q1 adjusted EPS 81c, consensus 78c

2026-05-11T23:16:06.000Z - 3 months ago

Novanta reports Q1 adjusted EPS 81c, consensus 78c


Novanta sees Q2 adjusted EPS 81c-86c, consensus 86c

2026-05-11T23:15:31.000Z - 3 months ago

Novanta sees Q2 adjusted EPS 81c-86c, consensus 86c


Novanta Announces Financial Results for the First Quarter 2026

May 11, 2026, 4:45 PM EDT - 3 months ago

Novanta Announces Financial Results for the First Quarter 2026


Novanta Proxy statement: Proxy filing

Apr 24, 2026, 8:00 AM EDT - 3 months ago

Novanta Proxy statement: Proxy filing


Novanta upgraded to Outperform from Neutral at Baird

2026-03-30T08:50:27.000Z - 4 months ago

Novanta upgraded to Outperform from Neutral at Baird


Novanta Joins NVIDIA Halos AI Systems Inspection Lab

Mar 16, 2026, 4:40 PM EDT - 5 months ago

Novanta Joins NVIDIA Halos AI Systems Inspection Lab


Novanta price target raised to $150 from $138 at Baird

2026-02-25T14:28:46.000Z - 5 months ago

Novanta price target raised to $150 from $138 at Baird


Novanta Earnings Call Transcript: Q4 2025

Feb 24, 2026, 8:00 AM EST - 5 months ago

Novanta Earnings Call Transcript: Q4 2025


Novanta Annual report: Q4 2025

Feb 24, 2026, 8:00 AM EST - 5 months ago

Novanta Annual report: Q4 2025


Novanta Earnings release: Q4 2025

Feb 24, 2026, 8:00 AM EST - 5 months ago

Novanta Earnings release: Q4 2025


Novanta Annual report: Q4 2025

Feb 24, 2026, 8:00 AM EST - 5 months ago

Novanta Annual report: Q4 2025


Novanta reports Q4 adjusted EPS 91c, consensus 88c

2026-02-23T21:51:07.000Z - 5 months ago

Novanta reports Q4 adjusted EPS 91c, consensus 88c


Novanta sees Q1 adjusted EPS 75c-80c, consensus 83c

2026-02-23T21:50:51.000Z - 5 months ago

Novanta sees Q1 adjusted EPS 75c-80c, consensus 83c


Novanta sees 2026 adjusted EPS $3.50-$3.65, consensus $3.61

2026-02-23T21:50:14.000Z - 5 months ago

Novanta sees 2026 adjusted EPS $3.50-$3.65, consensus $3.61


Novanta announces offering of 11M tangible equity units

2025-11-05T21:21:50.000Z - 9 months ago

Novanta announces offering of 11M tangible equity units


Novanta Inc. Announces Offering of Tangible Equity Units

Nov 5, 2025, 4:12 PM EST - 9 months ago

Novanta Inc. Announces Offering of Tangible Equity Units


Novanta Earnings Call Transcript: Q3 2025

Nov 4, 2025, 8:30 AM EST - 9 months ago

Novanta Earnings Call Transcript: Q3 2025


Novanta Quarterly report: Q3 2025

Nov 4, 2025, 8:30 AM EST - 9 months ago

Novanta Quarterly report: Q3 2025


Novanta Earnings release: Q3 2025

Nov 4, 2025, 8:30 AM EST - 9 months ago

Novanta Earnings release: Q3 2025


Novanta reports Q3 adjusted EPS 87c, consensus 82c

2025-11-03T22:05:58.000Z - 9 months ago

Novanta reports Q3 adjusted EPS 87c, consensus 82c


Novanta sees Q4 adjusted EPS 87c-93c, consensus 94c

2025-11-03T22:05:53.000Z - 9 months ago

Novanta sees Q4 adjusted EPS 87c-93c, consensus 94c


Novanta narrows FY25 adjusted EPS $3.24-$3.30 from $3.22-$3.36

2025-11-03T22:05:22.000Z - 9 months ago

Novanta narrows FY25 adjusted EPS $3.24-$3.30 from $3.22-$3.36


Novanta Announces Financial Results for the Third Quarter 2025

Nov 3, 2025, 5:00 PM EST - 9 months ago

Novanta Announces Financial Results for the Third Quarter 2025


Novanta Hosts ISO event for Humanoid Robot Safety Standards

Oct 24, 2025, 11:00 AM EDT - 10 months ago

Novanta Hosts ISO event for Humanoid Robot Safety Standards


Novanta Earnings Call Transcript: Q2 2025

Aug 5, 2025, 10:00 AM EDT - 1 year ago

Novanta Earnings Call Transcript: Q2 2025


Novanta Quarterly report: Q2 2025

Aug 5, 2025, 10:00 AM EDT - 1 year ago

Novanta Quarterly report: Q2 2025


Novanta Earnings release: Q2 2025

Aug 5, 2025, 10:00 AM EDT - 1 year ago

Novanta Earnings release: Q2 2025


Novanta Earnings Call Transcript: Q1 2025

May 6, 2025, 10:00 AM EDT - 1 year ago

Novanta Earnings Call Transcript: Q1 2025


Novanta Quarterly report: Q1 2025

May 6, 2025, 10:00 AM EDT - 1 year ago

Novanta Quarterly report: Q1 2025


Novanta Earnings release: Q1 2025

May 6, 2025, 10:00 AM EDT - 1 year ago

Novanta Earnings release: Q1 2025


Novanta Proxy statement: Proxy Filing

Apr 25, 2025, 8:00 AM EDT - 1 year ago

Novanta Proxy statement: Proxy Filing


Novanta Earnings Call Transcript: Q4 2024

Feb 25, 2025, 10:00 AM EST - 1 year ago

Novanta Earnings Call Transcript: Q4 2024


Novanta Annual report: Q4 2024

Feb 25, 2025, 10:00 AM EST - 1 year ago

Novanta Annual report: Q4 2024


Novanta Earnings release: Q4 2024

Feb 25, 2025, 10:00 AM EST - 1 year ago

Novanta Earnings release: Q4 2024


Novanta Earnings Call Transcript: Q3 2024

Nov 5, 2024, 10:00 AM EST - 1 year ago

Novanta Earnings Call Transcript: Q3 2024


Novanta Quarterly report: Q3 2024

Nov 5, 2024, 10:00 AM EST - 1 year ago

Novanta Quarterly report: Q3 2024


Novanta Earnings release: Q3 2024

Nov 5, 2024, 10:00 AM EST - 1 year ago

Novanta Earnings release: Q3 2024


Novanta Earnings Call Transcript: Q2 2024

Aug 6, 2024, 10:00 AM EDT - 2 years ago

Novanta Earnings Call Transcript: Q2 2024


Novanta Quarterly report: Q2 2024

Aug 6, 2024, 10:00 AM EDT - 2 years ago

Novanta Quarterly report: Q2 2024


Novanta Earnings release: Q2 2024

Aug 6, 2024, 10:00 AM EDT - 2 years ago

Novanta Earnings release: Q2 2024


Novanta Earnings Call Transcript: Q1 2024

May 7, 2024, 10:00 AM EDT - 2 years ago

Novanta Earnings Call Transcript: Q1 2024


Novanta Quarterly report: Q1 2024

May 7, 2024, 10:00 AM EDT - 2 years ago

Novanta Quarterly report: Q1 2024


Novanta Earnings release: Q1 2024

May 7, 2024, 10:00 AM EDT - 2 years ago

Novanta Earnings release: Q1 2024


Novanta Proxy statement: Proxy Filing

Apr 3, 2024, 8:00 AM EDT - 2 years ago

Novanta Proxy statement: Proxy Filing


Novanta Earnings Call Transcript: Q4 2023

Feb 28, 2024, 10:00 AM EST - 2 years ago

Novanta Earnings Call Transcript: Q4 2023


Novanta Annual report: Q4 2023

Feb 28, 2024, 10:00 AM EST - 2 years ago

Novanta Annual report: Q4 2023


Novanta Earnings release: Q4 2023

Feb 28, 2024, 10:00 AM EST - 2 years ago

Novanta Earnings release: Q4 2023


Novanta completes acquisition of Motion Solutions

Jan 2, 2024, 4:15 PM EST - 2 years ago

Novanta completes acquisition of Motion Solutions


Estimize
Estimize Jul. 30 at 11:03 AM
Wall St is expecting 0.83 EPS for $NOVT Q2 [Reporting 08/05 AMC] http://www.estimize.com/intro/novt?chart=historical&metric_name=eps&utm_co
0 · Reply
TrendStalker_
TrendStalker_ Jul. 19 at 7:49 PM
Humanoid robotics could become one of the biggest technology themes of the next decade. Goldman Sachs estimates the humanoid robot market could expand nearly 8X by 2035. Key names I’m watching: Sensors, Vision & Perception $OUST $AEVA $NOVT $IPGP The next wave of robotics will depend on more than just AI models. Hardware, sensing systems, and real-world perception will be critical pieces of the ecosystem.
0 · Reply
mattonline1
mattonline1 Jul. 17 at 5:29 PM
$NOVT — HOLD Q1 2026 revenue rose 10.4% YoY to $257.7M, but earnings still fell 13.4%, so the growth profile is not yet converting into cleaner profit. The balance sheet is a plus with net cash and 8.7% TTM free cash flow margin, but the stock already prices in a lot at 5.2x EV/revenue and 36.1x forward P/E. Gross margin of 44.2% shows the embedded product mix has quality, yet operating margin still needs to move toward 13% to 14% before the multiple looks easier to defend. Revenue above $260M and sustained margin expansion would support a higher rating, but at current valuation the setup looks more balanced than compelling. Full research: https://lf0.com/research/novanta-stock-analysis-novt/
0 · Reply
ParkerTradesX
ParkerTradesX Jul. 13 at 6:24 PM
Very hard to be bearish anything robotics, but most of all the actuator, bearings, and actuator components market. Since they account for more than 50% of the total BOM cost. And MS is expecting a 300x growth through to 2050. Here's some of the top names: $RBC: Humanoid opportunity is massive for RBC relative to the ~$50M they generate in revenue today. $RRX: Explained the humanoid opportunity as "when it takes off, it's going to take off quick." Trades far cheaper than RBC. Harmonic Drive (6324): Dominates the precision strain-wave gears inside actuators. And then the indirect winners would be: $NOVT: Robotics is already ~20% of Novanta's revenue with bookings up 50% YoY. $VPG: Quite a popular name on FinX and I think for good reason. Likely a key player in TSLA Optimus overall BOM. Every trading session creates new opportunities. Check profile info for more.
0 · Reply
EquityResearch6
EquityResearch6 Jul. 13 at 5:28 PM
Very hard to be bearish on robotics — especially the actuator, bearings, and actuator components market. Why? These components represent more than 50% of total BOM cost for many humanoid robots. Morgan Stanley expects the humanoid robotics market to grow 300x by 2050. Some names I’m watching: $RBC Humanoid robotics opportunity could be massive compared with its current ~$50M revenue base. $RRX Management described the humanoid opportunity as: “when it takes off, it’s going to take off quick.” Trades at a much lower valuation than $RBC. Harmonic Drive ($6324) Dominates precision strain-wave gears used inside robotic actuators. Indirect beneficiaries: $NOVT Robotics already represents ~20% of revenue, with bookings up 50% YoY. $VPG A popular robotics name with potential exposure to $TSLA Optimus’ overall BOM. The robotics theme is still early. The biggest winners may not just be the robot makers — they may be the companies supplying the critical components that every robot needs.
0 · Reply
UncleSteven
UncleSteven Jul. 7 at 5:37 PM
$NOVT is perhaps not yet "discovered" as a physical AI play. Only ~500 followers here.
0 · Reply
Dauphinoise
Dauphinoise Jul. 7 at 5:22 PM
$NOVT What the fuck happened here?!
1 · Reply
ParkerTradesX
ParkerTradesX Jul. 3 at 3:06 PM
5 Ways I'm Watching the Robotics Theme in 2026 $TER – AI chip testing and collaborative robots through Universal Robots. $NOVT – Precision photonics and motion technology for industrial and surgical robotics. $OUST – LiDAR and perception systems powering physical AI and autonomous machines. $HIMX – Vision and display chips helping robots process images and edge AI workloads. $AMBQ – Ultra-low-power edge AI for intelligent robots and connected devices. Robotics is becoming one of the biggest beneficiaries of the AI infrastructure buildout, and many of these names are still flying under the radar. The next list is about to be released. Are you going to miss out again? Which robotics stock would you add?
0 · Reply
babyloncapital
babyloncapital Jul. 3 at 2:25 PM
$MOG.A $NOVT $TKR starting positions in these names on next significant drop
1 · Reply
BobJohnBuoy666
BobJohnBuoy666 Jul. 2 at 10:39 PM
$NOVT largest position, let’s get this bread
0 · Reply
BobJohnBuoy666
BobJohnBuoy666 Jul. 1 at 1:04 PM
current largest positions $NOVT $IFF $CRSP
0 · Reply
BobJohnBuoy666
BobJohnBuoy666 Jun. 29 at 5:58 PM
$NOVT this is why you do your own market research; this could be a banger, less than 1k followers
0 · Reply
Stefgeek
Stefgeek Jun. 22 at 6:06 AM
$NOVT Time to buy guys? Greetings from Sweden.
0 · Reply
Dauphinoise
Dauphinoise Jun. 18 at 8:24 PM
Why can you be like $BFLY eh $NOVT ?
0 · Reply
prismmarketview
prismmarketview Jun. 10 at 2:30 PM
$NOVT to acquire Riverpoint Medical for up to $1.45B (1.2B upfront + 250M milestone), aiming to double recurring medical consumables revenue and raise medical exposure to ~60% of sales. #NOVT #MedTech #MNA #GrowthStocks https://prismmarketview.com/novantas-1-45-billion-dollar-riverpoint-buyout-doubles-down-on-surgical-consumables/
0 · Reply
notreload_ai
notreload_ai Jun. 9 at 12:23 PM
$NOVT to buy Riverpoint Medical for up to $1.45B, doubling its recurring medical consumables revenue and expanding into minimally invasive surgical devices. Deal expected to close Q3 2026. https://notreload.xyz/xy/novanta-acquires-riverpoint-medical/
0 · Reply
OpenOutcrier
OpenOutcrier Jun. 9 at 12:13 PM
$NOVT (-6.3% pre) Novanta Inc. Announces Acquisition of Riverpoint Medical https://ooc.bz/l/104579
0 · Reply
Wonderfulnewz
Wonderfulnewz Jun. 9 at 11:36 AM
$NOVT welp selling $300 million shares at $140 AND paying 10 x sales for a medical consumables business from a washing DC PE firm is quite a lot to swallow.
0 · Reply
OldPom
OldPom Jun. 9 at 10:36 AM
$NOVT interesting day
0 · Reply
Bernelius85
Bernelius85 May. 15 at 5:21 PM
$NOVT I’m in
0 · Reply
MarketBeat
MarketBeat May. 12 at 3:10 PM
https://marketbeat.com/a/8650680/ $NOVT Novanta Q1 Earnings Call Highlights
0 · Reply
TICKERTUTOR
TICKERTUTOR May. 12 at 1:36 PM
$NOVT this is going to be one of the prime beneficiaries for "robotics" just keep it on your watchlist
0 · Reply